Clinical Trials Directory

Trials / Completed

CompletedNCT05608616

Maternal and Fetal Outcomes in Pregnant Women With COVID -19,a Cross Sectional Study

COVID-19 and Pregnancy Maternal and Fetal Outcomes,A Retrospective Cross Sectional Study

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

The spread of a new coronavirus (SARS-CoV-2) from Wuhan, China, has been fast, and the World Health Organization (WHO) declared a pandemic on March 11th, 2020 .It has now spread worldwide and is one of the most severe public health threats.The clinical characteristics of COVID-19 and the likelihood of transmission vertically or during delivery in pregnant women are still unknown.

Detailed description

In this cross sectional study,the following questions require immediate attention: whether COVID-19 symptoms in pregnant women differ from symptoms in non-pregnant women; whether disease complications and mortality rates are higher in pregnant women than in non-pregnant women; and whether there is a risk of premature delivery, foetal mortality, or even vertical transmission of the disease. These questions must be answered in order to plan optimal obstetrical management for pregnant women with COVID-19

Conditions

Timeline

Start date
2022-04-01
Primary completion
2022-09-01
Completion
2022-10-01
First posted
2022-11-08
Last updated
2022-11-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05608616. Inclusion in this directory is not an endorsement.